{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:38:21Z","timestamp":1789659501038,"version":"4.0.1"},"reference-count":118,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,7,25]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>The enduring view of eosinophils, as immune effector cells whose primary function is host defence against infection by helminths and other microbial pathogens, sets the stage for a fundamental question regarding the safety of therapeutic eosinophil depletion. If eosinophils are significantly reduced or altogether depleted in an effort to alleviate the negative effects of tissue eosinophilia and eosinophilic inflammation in conditions such as asthma, COPD, chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome, would these patients become susceptible to infection or another illness? Development of mouse models in which the eosinophil lineage has been ablated, observations in patients naturally lacking eosinophils and data from studies of eosinophil-depleting medical therapies indicate that the absence of eosinophils is not detrimental to health. The evidence available to date, as presented in this review, supports the conclusion that even if certain homeostatic roles for the eosinophil may be demonstrable in controlled animal models and human<jats:italic>in vitro<\/jats:italic>settings, the evolution of the human species appears to have provided sufficient immune redundancy such that one may be hale and hearty without eosinophils.<\/jats:p>","DOI":"10.1183\/13993003.01217-2022","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T15:00:12Z","timestamp":1660230012000},"page":"2201217","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Living without eosinophils: evidence from mouse and man"],"prefix":"10.1183","volume":"61","author":[{"given":"David J.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"2024102103033512000_61.1.2201217.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.025"},{"key":"2024102103033512000_61.1.2201217.2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012419-032756"},{"key":"2024102103033512000_61.1.2201217.3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-093019-125918"},{"key":"2024102103033512000_61.1.2201217.4","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2010.2.2.87"},{"key":"2024102103033512000_61.1.2201217.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2016.05.004"},{"key":"2024102103033512000_61.1.2201217.6","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00127-19"},{"key":"2024102103033512000_61.1.2201217.7","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0624"},{"key":"2024102103033512000_61.1.2201217.8","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.3390\/ijms22158004","article-title":"Eosinophils and bacteria, the beginning of a story","volume":"22","author":"Ondari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024102103033512000_61.1.2201217.9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/JLB.4MR1117-473R","article-title":"Eosinophils in fungal diseases: an overview","volume":"104","author":"Figueiredo","year":"2018","journal-title":"J Leukoc Biol"},{"key":"2024102103033512000_61.1.2201217.10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00101"},{"key":"2024102103033512000_61.1.2201217.11","doi-asserted-by":"crossref","unstructured":"Jackson DJ , Munitz A . Safety of eosinophil depletion. In: Jackson DJ , Wechsler ME , eds. Eosinophilic Lung Diseases (ERS Monograph). Sheffield, European Respiratory Society, 2022; pp. 238\u2013252.","DOI":"10.1183\/2312508X.10030820"},{"key":"2024102103033512000_61.1.2201217.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.02.014"},{"key":"2024102103033512000_61.1.2201217.13","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.123"},{"key":"2024102103033512000_61.1.2201217.14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/imm.13110","article-title":"Gut eosinophils and their impact on the mucus-resident microbiota","volume":"158","author":"Singh","year":"2019","journal-title":"Immunology"},{"key":"2024102103033512000_61.1.2201217.15","doi-asserted-by":"publisher","DOI":"10.1126\/science.1201475"},{"key":"2024102103033512000_61.1.2201217.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.066"},{"key":"2024102103033512000_61.1.2201217.17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11154-018-9451-6","article-title":"Innate immune cells in the adipose tissue","volume":"19","author":"Chung","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"2024102103033512000_61.1.2201217.18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imcb.12407","article-title":"Can eosinophils in adipose tissue add fuel to the fire?","volume":"99","author":"Jacobsen","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"2024102103033512000_61.1.2201217.19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jdiacomp.2019.05.010","article-title":"Increased eosinophils in adipose tissue of metabolic syndrome","volume":"33","author":"Moussa","year":"2019","journal-title":"J Diabetes Complications"},{"key":"2024102103033512000_61.1.2201217.20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s42255-020-0228-3","article-title":"Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age","volume":"2","author":"Brigger","year":"2020","journal-title":"Nat Metab"},{"key":"2024102103033512000_61.1.2201217.21","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1111\/all.14956","article-title":"Effect of anti-IL-5 biologics on weight and body mass index","volume":"76","author":"Cusack","year":"2021","journal-title":"Allergy"},{"key":"2024102103033512000_61.1.2201217.22","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0295"},{"key":"2024102103033512000_61.1.2201217.23","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.4110\/in.2020.20.e24","article-title":"The emerging role of eosinophils as multifunctional leukocytes in health and disease","volume":"20","author":"Kim","year":"2020","journal-title":"Immune Netw"},{"key":"2024102103033512000_61.1.2201217.24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI95693"},{"key":"2024102103033512000_61.1.2201217.25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","article-title":"Eosinophils in COPD: just another biomarker?","volume":"5","author":"Bafadhel","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102103033512000_61.1.2201217.26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-020-00218-1","article-title":"Adult chronic rhinosinusitis","volume":"6","author":"Bachert","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2024102103033512000_61.1.2201217.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.05.020"},{"key":"2024102103033512000_61.1.2201217.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202003-0729LE"},{"key":"2024102103033512000_61.1.2201217.29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","article-title":"Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"2","author":"Brightling","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102103033512000_61.1.2201217.30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2024102103033512000_61.1.2201217.31","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00451-2020"},{"key":"2024102103033512000_61.1.2201217.32","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa1812185","article-title":"Benralizumab for PDGFRA-negative hypereosinophilic syndrome","volume":"380","author":"Kuang","year":"2019","journal-title":"N Engl J Med"},{"key":"2024102103033512000_61.1.2201217.33","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jaip.2022.02.037","article-title":"Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic gastrointestinal disease","volume":"10","author":"Kuang","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102103033512000_61.1.2201217.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"2024102103033512000_61.1.2201217.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"2024102103033512000_61.1.2201217.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708208"},{"key":"2024102103033512000_61.1.2201217.37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (synapse): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102103033512000_61.1.2201217.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702079"},{"key":"2024102103033512000_61.1.2201217.39","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2024102103033512000_61.1.2201217.40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0396OC"},{"key":"2024102103033512000_61.1.2201217.41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024102103033512000_61.1.2201217.42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-2600(19)30372-8","article-title":"Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials","volume":"8","author":"Bernstein","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024102103033512000_61.1.2201217.43","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1002\/lary.27564","article-title":"Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size","volume":"129","author":"Laidlaw","year":"2019","journal-title":"Laryngoscope"},{"key":"2024102103033512000_61.1.2201217.44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-835330"},{"key":"2024102103033512000_61.1.2201217.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07294.x"},{"key":"2024102103033512000_61.1.2201217.46","first-page":"PA1110","article-title":"Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma","volume":"48","author":"Austin","year":"2016","journal-title":"Eur Respir J"},{"key":"2024102103033512000_61.1.2201217.47","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/02770903.2018.1502301","article-title":"Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data","volume":"56","author":"Ortega","year":"2019","journal-title":"J Asthma"},{"key":"2024102103033512000_61.1.2201217.48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40264-020-00926-3","article-title":"Safety of eosinophil-depleting therapy for severe, eosinophilic asthma: focus on benralizumab","volume":"43","author":"Jackson","year":"2020","journal-title":"Drug Safety"},{"key":"2024102103033512000_61.1.2201217.49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.coi.2020.10.004","article-title":"Biologic treatment options for severe asthma","volume":"66","author":"Hearn","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"2024102103033512000_61.1.2201217.50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85664"},{"key":"2024102103033512000_61.1.2201217.51","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/all.15362","article-title":"Mouse resident lung eosinophils are dependent on IL-5","volume":"77","author":"Dolitzky","year":"2022","journal-title":"Allergy"},{"key":"2024102103033512000_61.1.2201217.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.021"},{"key":"2024102103033512000_61.1.2201217.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.08.004"},{"key":"2024102103033512000_61.1.2201217.54","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90333-6"},{"key":"2024102103033512000_61.1.2201217.55","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283551dbd"},{"key":"2024102103033512000_61.1.2201217.56","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666160119094313"},{"key":"2024102103033512000_61.1.2201217.57","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41568-020-0283-9","article-title":"A new dawn for eosinophils in the tumour microenvironment","volume":"20","author":"Grisaru-Tal","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2024102103033512000_61.1.2201217.58","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0196"},{"key":"2024102103033512000_61.1.2201217.59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020656"},{"key":"2024102103033512000_61.1.2201217.60","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099472"},{"key":"2024102103033512000_61.1.2201217.61","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015933"},{"key":"2024102103033512000_61.1.2201217.62","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00931-10"},{"key":"2024102103033512000_61.1.2201217.63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003988"},{"key":"2024102103033512000_61.1.2201217.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2007.04.006"},{"key":"2024102103033512000_61.1.2201217.65","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402219"},{"key":"2024102103033512000_61.1.2201217.66","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13071-019-3502-z","article-title":"Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R\/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils","volume":"12","author":"Frohberger","year":"2019","journal-title":"Parasit Vectors"},{"key":"2024102103033512000_61.1.2201217.67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.3.1577"},{"key":"2024102103033512000_61.1.2201217.68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101980"},{"key":"2024102103033512000_61.1.2201217.69","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0405OC"},{"key":"2024102103033512000_61.1.2201217.70","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/cea.13123","article-title":"Alternaria alternata challenge at the nasal mucosa results in eosinophilic inflammation and increased susceptibility to influenza virus infection","volume":"48","author":"Ma","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"2024102103033512000_61.1.2201217.71","doi-asserted-by":"crossref","first-page":"e12791","DOI":"10.1111\/pim.12791","article-title":"Eosinophils are dispensable for the regulation of IgA and TH17 responses in Giardia muris infection","volume":"43","author":"Yordanova","year":"2021","journal-title":"Parasite Immunol"},{"key":"2024102103033512000_61.1.2201217.72","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20172049"},{"key":"2024102103033512000_61.1.2201217.73","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3390\/microorganisms8111808","article-title":"Disrupting Bordetella immunosuppression reveals a role for eosinophils in coordinating the adaptive immune response in the respiratory tract","volume":"8","author":"Gestal","year":"2020","journal-title":"Microorganisms"},{"key":"2024102103033512000_61.1.2201217.74","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01990-14"},{"key":"2024102103033512000_61.1.2201217.75","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700078"},{"key":"2024102103033512000_61.1.2201217.76","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/eji.201948411","article-title":"TH2 cells promote eosinophil-independent pathology in a murine model of allergic bronchopulmonary aspergillosis","volume":"50","author":"Dietschmann","year":"2020","journal-title":"Eur J Immunol"},{"key":"2024102103033512000_61.1.2201217.77","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12931-021-01770-4","article-title":"Ameliorative effects of eosinophil deficiency on immune response, endoplasmic reticulum stress, apoptosis, and autophagy in fungus-induced allergic lung inflammation","volume":"22","author":"Wang","year":"2021","journal-title":"Respir Res"},{"key":"2024102103033512000_61.1.2201217.78","doi-asserted-by":"publisher","DOI":"10.1101\/gad.9.10.1250"},{"key":"2024102103033512000_61.1.2201217.79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.22.12355"},{"key":"2024102103033512000_61.1.2201217.80","doi-asserted-by":"publisher","DOI":"10.1111\/all.12169"},{"key":"2024102103033512000_61.1.2201217.81","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcmd.2017.01.008","article-title":"The targeted eosinophil-lowering effects of dexpramipexole in clinical studies","volume":"63","author":"Dworetzky","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"2024102103033512000_61.1.2201217.82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-2600(18)30406-5","article-title":"Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial","volume":"7","author":"Busse","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102103033512000_61.1.2201217.83","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"2024102103033512000_61.1.2201217.84","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8"},{"key":"2024102103033512000_61.1.2201217.85","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1016\/j.jaip.2021.07.058","article-title":"Integrated safety and efficacy among patients receiving benralizumab for up to 5\u2005years","volume":"9","author":"Korn","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102103033512000_61.1.2201217.86","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S2213-2600(17)30190-X","article-title":"Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"5","author":"Ferguson","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102103033512000_61.1.2201217.87","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","article-title":"Benralizumab for the prevention of COPD exacerbations","volume":"381","author":"Criner","year":"2019","journal-title":"N Engl J Med"},{"key":"2024102103033512000_61.1.2201217.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.08.2083"},{"key":"2024102103033512000_61.1.2201217.89","doi-asserted-by":"publisher","DOI":"10.1111\/all.14693"},{"key":"2024102103033512000_61.1.2201217.90","doi-asserted-by":"publisher","DOI":"10.1038\/nri2992"},{"key":"2024102103033512000_61.1.2201217.91","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S0031182016000111","article-title":"Strongyloides infection in rodents: immune response and immune regulation","volume":"144","author":"Breloer","year":"2017","journal-title":"Parasitology"},{"key":"2024102103033512000_61.1.2201217.92","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071836"},{"key":"2024102103033512000_61.1.2201217.93","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/JAA.S227170","article-title":"Two-year integrated efficacy and safety analysis of benralizumab in severe asthma","volume":"12","author":"FitzGerald","year":"2019","journal-title":"J Asthma Allergy"},{"key":"2024102103033512000_61.1.2201217.94","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/02770903.2019.1705333","article-title":"Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma","volume":"58","author":"Bourdin","year":"2021","journal-title":"J Asthma"},{"key":"2024102103033512000_61.1.2201217.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.07.010"},{"key":"2024102103033512000_61.1.2201217.96","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jaci.2018.09.033","article-title":"Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma","volume":"143","author":"Khatri","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2024102103033512000_61.1.2201217.97","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.clinthera.2019.07.007","article-title":"Long-term safety and clinical benefit of mepolizumab in patients with the most severe eosinophilic asthma: the COSMEX study","volume":"41","author":"Khurana","year":"2019","journal-title":"Clin Ther"},{"key":"2024102103033512000_61.1.2201217.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.055"},{"key":"2024102103033512000_61.1.2201217.99","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jaip.2017.08.024","article-title":"Long-term safety and efficacy of reslizumab in patients with eosinophilic asthma","volume":"5","author":"Murphy","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102103033512000_61.1.2201217.100","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0799-1"},{"key":"2024102103033512000_61.1.2201217.101","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa2106567","article-title":"Dupilumab in children with uncontrolled moderate-to-severe asthma","volume":"385","author":"Bacharier","year":"2021","journal-title":"N Engl J Med"},{"key":"2024102103033512000_61.1.2201217.102","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.101"},{"key":"2024102103033512000_61.1.2201217.103","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201803-0461OC"},{"key":"2024102103033512000_61.1.2201217.104","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201406-1039OC"},{"key":"2024102103033512000_61.1.2201217.105","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205465"},{"key":"2024102103033512000_61.1.2201217.106","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/all.13802","article-title":"Eosinophils capture viruses, a capacity that is defective in asthma","volume":"74","author":"Sabogal Pineros","year":"2019","journal-title":"Allergy"},{"key":"2024102103033512000_61.1.2201217.107","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/crj.12998","article-title":"Disseminated herpes zoster following treatment with benralizumab","volume":"13","author":"Mishra","year":"2019","journal-title":"Clin Respir J"},{"key":"2024102103033512000_61.1.2201217.108","unstructured":"AstraZeneca Pharmaceuticals LP . Fasenra (benralizumab) injection, for subcutaneous use [prescribing information]. 2017. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/F761070s000lbl.pdf Date last accessed: 2 August 2022."},{"key":"2024102103033512000_61.1.2201217.109","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/all.14465","article-title":"The role of peripheral blood eosinophil counts in COVID-19 patients","volume":"76","author":"Xie","year":"2021","journal-title":"Allergy"},{"key":"2024102103033512000_61.1.2201217.110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2021.06.006","article-title":"COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence","volume":"148","author":"Adir","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2024102103033512000_61.1.2201217.111","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1111\/all.15334","article-title":"Covid-19 in the absence of eosinophils: the outcome of confirmed SARS-COV-2 infection whilst on treatment with benralizumab","volume":"77","author":"Francis","year":"2022","journal-title":"Allergy"},{"key":"2024102103033512000_61.1.2201217.112","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jaip.2020.09.039","article-title":"Benralizumab for severe DRESS in two COVID-19 patients","volume":"9","author":"Schmid-Grendelmeier","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102103033512000_61.1.2201217.113","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.jaip.2021.06.047","article-title":"Benralizumab: a potential tailored treatment for life-threatening DRESS in the COVID-19 era","volume":"9","author":"Mesli","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102103033512000_61.1.2201217.114","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.jaip.2021.06.048","article-title":"Reply to \u201cBenralizumab: a potential tailored treatment for life-threatening dress in the COVID-19 era\u201d","volume":"9","author":"Lang","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102103033512000_61.1.2201217.115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4222"},{"key":"2024102103033512000_61.1.2201217.116","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0001OC"},{"key":"2024102103033512000_61.1.2201217.117","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2379"},{"key":"2024102103033512000_61.1.2201217.118","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jaip.2020.11.060","article-title":"Successful pregnancy in the setting of eosinophil depletion by benralizumab","volume":"9","author":"Manetz","year":"2021","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01217-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:08:32Z","timestamp":1740380912000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01217-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,12]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1183\/13993003.01217-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01217-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]}}}